Clinical Trial Update: Evaluation of the Role of Hydrocortisone Either Alone or Combined With Fludrocortisone in the Outcome of Septic Shock in Adults [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating hydrocortisone alone or with fludrocortisone for outcomes in adults with septic shock; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Fludrocortisone (Fludrocortisone)
• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Ain Shams University | Conditions: Septic Shock | Phase 4 | Status: COMPLETED